| Serial Number | 79301184 |
| Word Mark | COVID 19 SENTINEL |
| Filing Date | Wednesday, September 30, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, January 25, 2022 |
| Registration Number | 6624276 |
| Registration Date | Tuesday, January 25, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 9, 2021 |
| Pseudo Mark | COVID NINETEEN SENTINEL; COVID ONE NINE SENTINEL |
| Goods and Services | Medical testing services, namely, blood testing, saliva, urine, tissue, hair and body fluid testing services for diagnostic or treatment purposes; serological and urinary testing services for medical, epidemiological purposes; medical testing services in the field of epidemiology and genetics; DNA and RNA analyses for medical testing; DNA and RNA screening for medical testing purposes; viral screening for medical testing purposes; medical and health assessment services in connection with DNA and RNA; genetic testing for medical purposes; hospital services; medical assistance services and medical services in the field of epidemiology and genetics; medical clinic services; medical consultation services; medical consultation in the fields of genetics and epidemiology; maintaining patient medical record online; collection, sampling and preservation of human blood, saliva, urine, tissue, hair and body fluids for medical purposes; medical testing for diagnostic and epidemiological treatment purposes; medical testing for epidemiological diagnosis purposes; medical testing for diagnostic purposes in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of test panels in the field of preventive medicine; medical testing for diagnostic or treatment purposes featuring the carrying out of medical biology test panels and the interpretation of medical biology test results; providing bio-pathological medical information and advice relating to medical biology tests; medical testing for diagnostic and treatment purposes featuring testing for assessing immunogenicity, hypersensitivity and adverse immune stimulation; medical testing for diagnostic or treatment purposes in the field of infectious diseases; prenatal diagnostic testing for medical purposes |
| Disclaimer with Predetermined Text | "COVID 19" |
| Goods and Services | Scientific research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, and biochemistry; industrial research in the field of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; scientific research and development in the fields of animal and plant biology, physical chemistry, microbiology, molecular biology, epidemiology, immunology, chemistry, biochemistry; carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological or immunological analyses, clinical and in-vitro studies in the feed, agro, chemical, cosmetic, personal care, agrochemical, biotechnology, aero-space, automobile, consumer products, semiconductor, electronics, energy, magnetic storage and any science-oriented industries and in environmental testing; carrying out scientific study and research in the fields of genetic analyses in the fields of plant and animal products; carrying out scientific study and research in the fields of genetic analyses in the feed, agro, chemical, cosmetic, personal care, biotechnology and consumer products industries; development of methods, namely, establishment and carrying out scientific study and research in the fields of physical, chemical, physical-chemical, biochemical, biological, epidemiological, microbiological, molecular biological, immunological and biomolecular testing methods; scientific research, medical research and industrial engineering research resulting in expert reports for scientists and engineers; professional consultancy in the fields of scientific and medical research and research on medical treatments; DNA, RNA and virus analyses for scientific purposes; technical project studies; gene libraries, namely, collections of DNA and RNA fragments, variants or combination of genes for medical or veterinary use; scientific and technological services, namely, scientific research, scientific analysis, scientific research consulting, industrial design, engineering, scientific development and genetic laboratory testing services for research purposes for others in the field of genetics and epidemiology; scientific research featuring on-line data collection and provision, data interpretation, consultancy and advisory services related to feed testing services; database design and development; providing online information about industrial analysis and research services in the fields of environmental testing, genetics and epidemiology; providing scientific research information including scientific analysis data and results from an online searchable database; information technology services, namely, providing an online searchable database with algorithms in the field of scientific research analysis results based on genomics data; providing online information in the field of technological research relating to environmental testing, genetics and epidemiology from a computer database or the internet; new product development and research in the fields of biotech products, chemicals and agro-chemicals; scientific research services in the areas of genomics, proteomics, chemistry, biology, epidemiology medicinal chemistry, organic and inorganic chemistry, synthetic chemistry, analogue chemistry and computational chemistry; providing scientific information in the field of epidemiology, genomics and proteomics of living organisms including human beings based on existing biological data by using information technology tools and techniques; conducting clinical trials for others in the fields of cosmetics and personal care products; scientific research featuring the use of information technology tools and techniques to work with existing biological data and to generate information on the epidemiology, genomics and proteomics of living organs including human beings through research and study; scientific and technological services, namely, scientific and medical laboratory services, laboratory research and development in the fields of epidemiology, biomedicine and biobanking; consultation and analysis services for scientific research purposes in the fields of biotechnology, medical diagnostics and drug therapy; DNA and RNA analyses for scientific purposes; DNA and RNA screening for scientific purposes; viral screening for scientific purposes |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2021 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EUROFINS SCIENTIFIC (IRELAND) LIMITED |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | IE |
| Party Name | EUROFINS SCIENTIFIC (IRELAND) LIMITED |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | IE |
| Party Name | EUROFINS SCIENTIFIC (IRELAND) LIMITED |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | IE |
| Event Date | Event Description |
| Monday, August 22, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Tuesday, July 5, 2022 | GENERIC MADRID TRANSACTION SENT TO IB |
| Tuesday, July 5, 2022 | GENERIC MADRID TRANSACTION CREATED |
| Monday, April 25, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, January 25, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, November 9, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 9, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, October 20, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, October 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, September 9, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 9, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 9, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 5, 2021 | REFUSAL PROCESSED BY IB |
| Wednesday, March 17, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, March 17, 2021 | REFUSAL PROCESSED BY MPU |
| Friday, March 12, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, March 11, 2021 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 10, 2021 | ASSIGNED TO EXAMINER |
| Tuesday, March 2, 2021 | ASSIGNED TO EXAMINER |
| Thursday, February 25, 2021 | ASSIGNED TO EXAMINER |
| Friday, January 8, 2021 | APPLICATION FILING RECEIPT MAILED |
| Monday, January 4, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, December 31, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |